| CXHL1500141 | AZD3759 | zorifertinib | Active ingredient | Chemical Drugs(1.1) | New Drug Application | 2015-04-23 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2016-03-17 | view |
| CXHL1500142 | AZD3759片 | zorifertinib | Tablet | Chemical Drugs(1.1) | New Drug Application | 2015-04-23 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2016-03-17 | view |
| CXHL1500143 | AZD3759片 | zorifertinib | Tablet | Chemical Drugs(1.1) | New Drug Application | 2015-04-23 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2016-03-17 | view |
| CXHL1500144 | AZD3759片 | zorifertinib | Tablet | Chemical Drugs(1.1) | New Drug Application | 2015-04-23 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2016-03-17 | view |
| JXHB2000049 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs | Supplementary Application | 2020-11-20 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2020-11-20 | view |
| JXHB2000050 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs | Supplementary Application | 2020-11-20 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2020-11-20 | view |
| JXHB2100001 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs | Supplementary Application | 2021-01-06 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2021-01-05 | view |
| JXHB2100002 | 奥拉帕利片 | olaparib | Tablet | Chemical Drugs | Supplementary Application | 2021-01-06 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2022-01-20 | view |
| JXHL1400342 | 艾塞那肽微球注射液 | Exenatide | Injection | Chemical Drugs | Import Drug Application | 2014-10-30 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2016-03-29 | view |
| JXHL1400343 | 艾塞那肽微球注射液 | Exenatide | Injection | Chemical Drugs | Import Drug Application | 2014-10-30 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2016-03-29 | view |
| JXHL1500156 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Import Drug Application | 2015-07-10 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2017-03-23 | view |
| JXHL1500157 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Import Drug Application | 2015-07-10 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2017-03-23 | view |
| JXHL1500158 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Import Drug Application | 2015-07-10 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2017-03-23 | view |
| JXHL1500159 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Import Drug Application | 2015-07-10 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2017-03-23 | view |
| JXHL1500160 | 艾塞那肽注射液 | Exenatide | Injection | Chemical Drugs | Import Drug Application | 2015-07-10 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2016-09-05 | view |
| JXHL1500161 | 艾塞那肽注射液 | Exenatide | Injection | Chemical Drugs | Import Drug Application | 2015-07-10 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2016-09-05 | view |
| JXHL1600006 | 利那洛肽胶囊 | linaclotide | Capsule | Chemical Drugs | Import Drug Application | 2016-01-31 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2019-01-15 | view |
| JXHL1600007 | 利那洛肽胶囊 | linaclotide | Capsule | Chemical Drugs | Import Drug Application | 2016-01-21 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2019-01-15 | view |
| JXHL1600062 | 环硅酸锆钠口服干混悬剂 | sodium zirconium cyclosilicate | Suspension | Chemical Drugs | Import Drug Application | 2016-06-15 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2017-03-15 | view |
| JXHL1600063 | 环硅酸锆钠口服干混悬剂 | sodium zirconium cyclosilicate | Suspension | Chemical Drugs | Import Drug Application | 2016-06-15 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2017-03-15 | view |
